Cited by 2,310Statistical Methods in Clinical TrialsProbability and Statistical ResearchStatistical Methods and Bayesian Inference

The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.

Discrete sequential boundaries for clinical trials

GORDON LAN, K. K., DEMETS, DAVID L.·1983·Biometrika

DOI 10.1093/biomet/70.3.659

Open this paper in CoChat — free account

Abstract

Pocock (1977), O'Brien & Fleming (1979) and Slud & Wei (1982) have proposed different methods to construct discrete sequential boundaries for clinical trials. These methods require that the total number of decision times be specified in advance. In the present paper, we propose a more flexible way to construct discrete sequential boundaries. The method is based on the choice of a function, α*(t), which characterizes the rate at which the error level α is spent. The boundary at a decision time is determined by α*(t), and by past and current decision times, but does not depend on the future decision times or the total number of decision times.

Integrity signals

Registry

Crossref · 10.1093/biomet/70.3.659

Cites

10 of 10 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

A Multiple Testing Procedure for Clinical Trials
O'Brien, P. C., & Fleming, T. R. (1979) · Biometrics · doi:10.2307/2530245 · Cited by 3,311
Group sequential methods in the design and analysis of clinical trials
POCOCK, S. J. (1977) · Biometrika · doi:10.1093/biomet/64.2.191 · Cited by 1,831
Repeated Significance Tests on Accumulating Data
Armitage, P., McPherson, C. K., & Rowe, B. C. (1969) · Journal of the Royal Statistical Society Series A (General) · doi:10.2307/2343787 · Cited by 772
Stochastically curtailed tests in long–term clinical trials
Lan, K. K. G., Simon, R. M., & Halperin, M. (1982) · Sequential Analysis · doi:10.1080/07474948208836014 · Cited by 356
Interim Analyses for Randomized Clinical Trials: The Group Sequential Approach
Pocock, S. (1982) · Biometrics · doi:10.2307/2530298 · Cited by 265
Two-Sample Repeated Significance Tests Based on the Modified Wilcoxon Statistic
SLUD, E. V., & Wei, L. (1982) · Journal of the American Statistical Association · doi:10.1080/01621459.1982.10477899 · Cited by 244
Crossing probabilities for a square root boundary by a bessel process
Long, D. M. D. (1981) · Communication in Statistics- Theory and Methods · doi:10.1080/03610928108828182 · Cited by 135
Sequential Testing of the Equality of Two Survival Distributions Using the Modified Savage Statistic
Koziol, J. A., & Petkau, A. J. (1978) · Biometrika · doi:10.1093/biomet/65.3.615 · Cited by 38
A two sample wilcoxon test for progressively censored data
DAVIS, C. E. (1978) · Communication in Statistics- Theory and Methods · doi:10.1080/03610927808827630 · Cited by 23
Rank order tests for grouped data under progressive censoring
Majumdar, H., & Sen, P. K. (1977) · Communication in Statistics- Theory and Methods · doi:10.1080/03610927708827511 · Cited by 9

Show all 10 references

Sorted by citations

Items 501–600 of 1,001

Randomized placebo-controlled evaluation of hydrazine sulfate in patients with advanced colorectal cancer.
Loprinzi, C. L., Kuross, S. A., O'Fallon, J. R., Gesme, D. H., Gerstner, J. B., Rospond, R. M., Cobau, C. D., & Goldberg, R. M. (1994) · Journal of Clinical Oncology · doi:10.1200/jco.1994.12.6.1121 · Cited by 106
Effects of Vegetarian Diets on Blood Pressure Lowering: A Systematic Review with Meta-Analysis and Trial Sequential Analysis
Lee, K. W., Loh, H. C., Ching, S. M., Devaraj, N. K., & Hoo, F. K. (2020) · Nutrients · doi:10.3390/nu12061604 · Cited by 105
Late First-Trimester Invasive Prenatal Diagnosis: Results of an International Randomized Trial
Philip, J., Silver, R. K., Wilson, R. D., Thom, E. A., Zachary, J. M., Mohide, P., Mahoney, M. J., Simpson, J. L., Platt, L. D., Pergament, E., et al. (2004) · Obstetrics and Gynecology · doi:10.1097/01.aog.0000128049.73556.fb · Cited by 105
Group Sequential Tests for Delayed Responses (with discussion)
Hampson, L. V., & Jennison, C. (2012) · Journal of the Royal Statistical Society Series B (Statistical Methodology) · doi:10.1111/j.1467-9868.2012.01030.x · Cited by 104
Randomized Phase III Study of 5-Fluorouracil Continuous Infusion vs. Sequential Methotrexate and 5-Fluorouracil Therapy in Far Advanced Gastric Cancer with Peritoneal Metastasis (JCOG0106)
Shirao, K., Boku, N., Yamada, Y., Yamaguchi, K., Doi, T., Goto, M., Nasu, J., Denda, T., Hamamoto, Y., Takashima, A., et al. (2013) · Japanese Journal of Clinical Oncology · doi:10.1093/jjco/hyt114 · Cited by 104
Group Sequential Clinical Trials: A Classical Evaluation of Bayesian Decision-Theoretic Designs
Lewis, R. J., & Berry, D. A. (1994) · Journal of the American Statistical Association · doi:10.1080/01621459.1994.10476893 · Cited by 104
Multicenter Randomized Trial of Robot-Assisted Rehabilitation for Chronic Stroke: Methods and Entry Characteristics for VA ROBOTICS
Lo, A., Guarino, P., Krebs, H. I., Volpe, B. T., Bever, C. T., Duncan, P. W., Ringer, R. J., Wagner, T. H., Richards, L. G., Bravata, D. M., et al. (2009) · Neurorehabilitation and neural repair · doi:10.1177/1545968309338195 · Cited by 104
One-Sided Sequential Stopping Boundaries for Clinical Trials: A Decision- Theoretic Approach
Berry, D. A., & Ho, C.-H. (1988) · Biometrics · doi:10.2307/2531909 · Cited by 104
Study design of the Medical Therapy of Prostatic Symptoms (MTOPS) trial
Bautista, O. M., Kusek, J. W., Nyberg, L. M., McConnell, J. D., Bain, R. P., Miller, G. J., Crawford, E. D., Kaplan, S. A., Sihelnik, S. A., Brawer, M. K., et al. (2003) · Controlled Clinical Trials · doi:10.1016/s0197-2456(02)00263-5 · Cited by 103
A Randomized Trial of the Duration of Therapy with Metronidazole plus or minus Azithromycin for Treatment of Symptomatic Bacterial Vaginosis
Schwebke, J. R., & Desmond, R. A. (2006) · Clinical Infectious Diseases · doi:10.1086/509577 · Cited by 103
Systematic Reviews of Anesthesiologic Interventions Reported as Statistically Significant
Imberger, G. L., Gluud, C. N., Boylan, J. F., & Wetterslev, J. (2015) · Anesthesia & Analgesia · doi:10.1213/ane.0000000000000892 · Cited by 102
Final Overall Survival Analysis of the TOURMALINE-MM1 Phase III Trial of Ixazomib, Lenalidomide, and Dexamethasone in Patients With Relapsed or Refractory Multiple Myeloma
Richardson, P. G. G., Kumar, S. K., Masszi, T., Grząśko, N., Bahlis, N. J., Hansson, M., Pour, L., Sandhu, I., Ganly, P. S., Baker, B. W., et al. (2021) · Journal of Clinical Oncology · doi:10.1200/jco.21.00972 · Cited by 102
Oral gepotidacin versus nitrofurantoin in patients with uncomplicated urinary tract infection (EAGLE-2 and EAGLE-3): two randomised, controlled, double-blind, double-dummy, phase 3, non-inferiority trials
Wagenlehner, F. R. A., Perry, C., Hooton, T. M., Scangarella-Oman, N. E., Millns, H., Powell, M., Jarvis, E., Dennison, J., Sheets, A., Butler, D. A., et al. (2024) · The Lancet · doi:10.1016/s0140-6736(23)02196-7 · Cited by 102
L-Carnitine Supplementation for the Management of Fatigue in Patients With Cancer: An Eastern Cooperative Oncology Group Phase III, Randomized, Double-Blind, Placebo-Controlled Trial
Cruciani, R. A., Zhang, J. J., Manola, J. B., Cella, D. F., Ansari, B. A., & Fisch, M. J. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2011.40.2180 · Cited by 102
A randomized, placebo- and active-controlled study of paliperidone extended-release as maintenance treatment in patients with bipolar I disorder after an acute manic or mixed episode
Berwaerts, J., Melkote, R., Nuamah, I., & Lim, P. (2012) · Journal of Affective Disorders · doi:10.1016/j.jad.2012.01.047 · Cited by 101
Adding flexibility to clinical trial designs: an example-based guide to the practical use of adaptive designs
Burnett, T. D., Mozgunov, P., Pallmann, P., Villar, S. S., Wheeler, G., & Jaki, T. (2020) · BMC Medicine · doi:10.1186/s12916-020-01808-2 · Cited by 101
Planning and Analyzing Adaptive Group Sequential Survival Trials
Wassmer, G. (2006) · Biometrical Journal · doi:10.1002/bimj.200510190 · Cited by 101
The what, why and how of bayesian clinical trials monitoring
Freedman, L. S., Spiegelhalter, D. J., & Parmar, M. (1994) · Statistics in Medicine · doi:10.1002/sim.4780131312 · Cited by 101
Effect of Amlodipine on the Survival of Patients With Severe Chronic Heart Failure Due to a Nonischemic Cardiomyopathy
Packer, M., Carson, P. E., Elkayam, U., Konstam, M. A., Moe, G. W. P. L., O’Connor, C. J., Rouleau, J. L., Schocken, D. D., Anderson, S. A., & DeMets, D. L. (2013) · JACC Heart Failure · doi:10.1016/j.jchf.2013.04.004 · Cited by 100
Self-citation
A phase III randomized trial of thalidomide plus zoledronic acid versus zoledronic acid alone in patients with asymptomatic multiple myeloma
Witzig, T. E., Laumann, K. M., Lacy, M. Q., Hayman, S. R., Dispenzieri, A. A., Kumar, S. K., Reeder, C. B., Roy, V., Lust, J. A., Gertz, M. A., et al. (2012) · Leukemia · doi:10.1038/leu.2012.236 · Cited by 100
The Stroke Hyperglycemia Insulin Network Effort (SHINE) Trial Protocol: A Randomized, Blinded, Efficacy Trial of Standard vs. Intensive Hyperglycemia Management in Acute Stroke
Bruno, A., Durkalski, V., Hall, C. E., Juneja, R., Barsan, W. G., Janis, S., Meurer, W. J., Fansler, A. C., & Johnston, K. C. (2013) · International Journal of Stroke · doi:10.1111/ijs.12045 · Cited by 98
A Unifying Family of Group Sequential Test Designs
Kittelson, J. M., & Emerson, S. S. (1999) · Biometrics · doi:10.1111/j.0006-341x.1999.00874.x · Cited by 98
Exact Confidence Intervals Following a Group Sequential Trial: A Comparison of Methods
Rosner, G. L., & Tsiatis, A. A. (1988) · Biometrika · doi:10.1093/biomet/75.4.723 · Cited by 97
To adjust, or not to adjust, for multiple comparisons
Hooper, R. (2025) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2025.111688 · Cited by 97
An adaptive method for establishing a dose‐response relationship
Bauer, P., & Röhmel, J. (1995) · Statistics in Medicine · doi:10.1002/sim.4780141410 · Cited by 96
Sequential design approaches for bioequivalence studies with crossover designs
Potvin, D., DiLiberti, C. E., Hauck, W. W., Parr, A. F., Schuirmann, D. J., & Smith, R. A. (2007) · Pharmaceutical Statistics · doi:10.1002/pst.294 · Cited by 95
Antithrombin III in critically ill patients: systematic review with meta-analysis and trial sequential analysis
Afshari, A., Wetterslev, J., Brok, J. S., & Møller, A. M. (2007) · BMJ · doi:10.1136/bmj.39398.682500.25 · Cited by 94
Flexible Sample Size Considerations Using Information-Based Interim Monitoring
Mehta, C. R., & Tsiatis, A. A. (2001) · Drug Information Journal · doi:10.1177/009286150103500407 · Cited by 94
Venous Thromboembolic Events Associated With Hormone Replacement Therapy
Grady, D. G. (1997) · JAMA · doi:10.1001/jama.1997.03550060053030 · Cited by 94
First-Attempt Intubation Success of Video Laryngoscopy in Patients with Anticipated Difficult Direct Laryngoscopy
Aziz, M. F., Abrons, R. O., Cattano, D., Bayman, E. O., Swanson, D., Hagberg, C. A., Todd, M. M., & Brambrink, A. M. (2015) · Anesthesia & Analgesia · doi:10.1213/ane.0000000000001084 · Cited by 93
Detecting multiple change points in piecewise constant hazard functions
Goodman, M. S., Li, Y., & Tiwari, R. C. (2011) · Journal of Applied Statistics · doi:10.1080/02664763.2011.559209 · Cited by 93
Trimetrexate with Leucovorin versus Trimethoprim-Sulfamethoxazole for Moderate to Severe Episodes of Pneumocystis carinii Pneumonia in Patients with AIDS: A Prospective, Controlled Multicenter Investigation of the AIDS Clinical Trials Group Protocol 029/031
Sattler, F. R., Frame, P., Davis, R. B., Nichols, L., Shelton, B. J., Akil, B., Baughman, R. P., Hughlett, C., Weiss, W., Boylen, C. T., et al. (1994) · The Journal of Infectious Diseases · doi:10.1093/infdis/170.1.165 · Cited by 93
Fludarabine plus alemtuzumab versus fludarabine alone in patients with previously treated chronic lymphocytic leukaemia: a randomised phase 3 trial
Elter, T., Gercheva, L., Pylylpenko, H., Robak, T., Jaksic, B. S., Rekhtman, G. B., Kyrcz‐Krzemień, S., Vatutin, M. T., Wu, J., Sirard, C. A., et al. (2011) · The Lancet Oncology · doi:10.1016/s1470-2045(11)70242-x · Cited by 92
Biostatistics and Bayes
Breslow, N. E. (1990) · Statistical Science · doi:10.1214/ss/1177012092 · Cited by 90
Overrunning and underrunning in sequential clinical trials
Whitehead, J. (1992) · Controlled Clinical Trials · doi:10.1016/0197-2456(92)90017-t · Cited by 92
Design and Statistical Aspects of the African American Study of Kidney Disease and Hypertension (AASK)
Gassman, J., Greene, T., Wright, J. T., Agodoa, L. Y. C., Bakris, G. L., Beck, G. J., Douglas, J. G., Jamerson, K., Lewis, J. B., Kutner, M., et al. (2003) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000070080.21680.cb · Cited by 92
Rationale and Design for the Controlled ONset Verapamil INvestigation of Cardiovascular Endpoints (CONVINCE) Trial
Black, H. R., Elliott, W. J., Neaton, J. D., Grandits, G. A., Grambsch, P. M., Grimm, R. H., Hansson, L., Lacoucière, Y., Muller, J. E., Sleight, P., et al. (1998) · Controlled Clinical Trials · doi:10.1016/s0197-2456(98)00013-0 · Cited by 92
Cancer risk with topical calcineurin inhibitors, pimecrolimus and tacrolimus, for atopic dermatitis: a systematic review and meta-analysis
Devasenapathy, N., Chu, A. W. L., Wong, M., Srivastava, A., Ceccacci, R., Lin, C., MacDonald, M., Wen, A., Steen, J. P., Levine, M., et al. (2022) · The Lancet Child & Adolescent Health · doi:10.1016/s2352-4642(22)00283-8 · Cited by 94
Lymphadenectomy in Locally Advanced Cervical Cancer Study (LiLACS): Phase III Clinical Trial Comparing Surgical With Radiologic Staging in Patients With Stages IB2–IVA Cervical Cancer
Frumovitz, M., Querleu, D., Gil‐Moreno, A., Morice, P., Jhingran, A., Munsell, M. F., Macapinlac, H. A., Leblanc, É., Martínez, A., & Ramirez, P. T. (2013) · Journal of Minimally Invasive Gynecology · doi:10.1016/j.jmig.2013.07.007 · Cited by 91
A randomised Phase III trial of glufosfamide compared with best supportive care in metastatic pancreatic adenocarcinoma previously treated with gemcitabine
Ciuleanu, T., Pavlovsky, A. V., Bodoky, G., Garin, A. M., Langmuir, V. K., Kroll, S., & Tidmarsh, G. F. (2009) · European Journal of Cancer · doi:10.1016/j.ejca.2008.12.022 · Cited by 91
Adaptive Clinical Trials: Advantages and Disadvantages of Various Adaptive Design Elements
Korn, E. L., & Freidlin, B. (2017) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djx013 · Cited by 90
Hierarchical testing of multiple endpoints in group‐sequential trials
Glimm, E., Maurer, W., & Bretz, F. (2010) · Statistics in Medicine · doi:10.1002/sim.3748 · Cited by 89
Bromfenac Ophthalmic Solution 0.09% (Xibrom) for Postoperative Ocular Pain and Inflammation
Donnenfeld, E. D., Holland, E. J., Stewart, R. H., Gow, J. A., & Grillone, L. R. (2007) · Ophthalmology · doi:10.1016/j.ophtha.2006.12.029 · Cited by 89
Early Detection of Reliability Problems Using Information From Warranty Databases
Wu, H., & Meeker, W. Q. (2002) · Technometrics · doi:10.1198/004017002317375073 · Cited by 89
Practical aspects in data monitoring: A brief review
DeMets, D. L. (1987) · Statistics in Medicine · doi:10.1002/sim.4780060706 · Cited by 89
Self-citation
A conditional maximized sequential probability ratio test for Pharmacovigilance
Li, L., & Kulldorff, M. (2009) · Statistics in Medicine · doi:10.1002/sim.3780 · Cited by 88
Melphalan, prednisone, and thalidomide vs melphalan, prednisone, and lenalidomide (ECOG E1A06) in untreated multiple myeloma
Stewart, A. K., Jacobus, S. J., Fonseca, R., Weiss, M., Callander, N. S., Chanan-Khan, A. A., & Rajkumar, S. V. (2015) · Blood · doi:10.1182/blood-2014-12-613927 · Cited by 88
Restricted peri-operative fluid administration adjusted by serum lactate level improved outcome after major elective surgery for gastrointestinal malignancy
Yu, W., Ning, L., JianFeng, G., Wei-qin, L., ShaoQiu, T., Zhihui, T., Tao, G., JuanJuan, Z., Xi, F., Hui, S., et al. (2009) · Surgery · doi:10.1016/j.surg.2009.10.036 · Cited by 88
Sulphonylurea monotherapy for patients with type 2 diabetes mellitus
Hemmingsen, B., Schroll, J. B., Lund, S. S., Wetterslev, J., Gluud, C. N., Vaag, A. A., Sonne, D. P., Lundstrøm, L. H., & Almdal, T. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009008.pub2 · Cited by 89
Retracted
Development of the Flexibility in Duty Hour Requirements for Surgical Trainees (FIRST) Trial Protocol: A National Cluster-Randomized Trial of Resident Duty Hour Policies
Bilimoria, K. Y., Chung, J. W., Hedges, L. V., Dahlke, A. R., Love, R., Cohen, M. E., Tarpley, J., Mellinger, J., Mahvi, D. M., Kelz, R. R., et al. (2016) · JAMA Surgery · doi:10.1001/jamasurg.2015.4990 · Cited by 87
A randomized Phase III trial of adjuvant S-1 therapy vs. observation alone in resected biliary tract cancer: Japan Clinical Oncology Group Study (JCOG1202, ASCOT)
Nakachi, K., Konishi, M., Ikeda, M., Mizusawa, J., Eba, J., Okusaka, T., Ishii, H., Fukuda, H., & Furuse, J. (2018) · Japanese Journal of Clinical Oncology · doi:10.1093/jjco/hyy004 · Cited by 87
Randomization: The forgotten component of the randomized clinical trial
Rosenberger, W. F., Uschner, D., & Wang, Y. (2018) · Statistics in Medicine · doi:10.1002/sim.7901 · Cited by 87
A Double-Blind, Randomized, Placebo-Controlled Trial of Olanzapine in the Prevention of Psychotic Relapse
Beasley, C. M., Sutton, V. K., Hamilton, S. H., Walker, D. J., Dossenbach, M. R. K., Taylor, C. C., Alaka, K., Bykowski, D., & Tollefson, G. D. (2003) · Journal of Clinical Psychopharmacology · doi:10.1097/01.jcp.0000095348.32154.ec · Cited by 87
Design and rationale of the Clinical Outcomes Utilizing Revascularization and Aggressive DruG Evaluation (COURAGE) trial
Boden, W. E., O’Rourke, R. A., Teo, K. K., Hartigan, P. M., Maron, D. J., Kostuk, W. J., Knudtson, M. L., Dada, M. R., Casperson, P. R., Harris, C. L., et al. (2006) · American Heart Journal · doi:10.1016/j.ahj.2005.08.015 · Cited by 87
Frequentist evaluation of group sequential clinical trial designs
Emerson, S. S., Kittelson, J. M., & Gillen, D. L. (2007) · Statistics in Medicine · doi:10.1002/sim.2901 · Cited by 87
Confidence Intervals Associated with Tests for Bioequivalence
Hsu, J. C., Hwang, J. T. G., Liu, H.-K., & Ruberg, S. J. (1994) · Biometrika · doi:10.1093/biomet/81.1.103 · Cited by 87
A Randomized, Controlled, Double-Blind Study Comparing the Survival Benefit of Four Different Reverse Transcriptase Inhibitor Therapies (Three-Drug, Two-Drug, and Alternating Drug) for the Treatment of Advanced AIDS
Henry, K., Erice, A., Tierney, C., Balfour, H. H., Fischl, M. A., Kmack, A., Liou, S.-H., Kenton, A., Hirsch, M., Phair, J., et al. (1998) · Journal of Acquired Immune Deficiency Syndromes & Human Retrovirology · doi:10.1097/00042560-199812010-00004 · Cited by 86
Data Monitoring in Clinical Trials
(2006) · Springer eBooks · doi:10.1007/0-387-30107-0 · Cited by 86
Effects of avoidance or use of neuromuscular blocking agents on outcomes in tracheal intubation: a Cochrane systematic review
Lundstrøm, L. H., Duez, C. H. V., Nørskov, A. K., Rosenstock, C. V., Thomsen, J. L., Møller, A. M., Strande, S., & Wetterslev, J. (2018) · British Journal of Anaesthesia · doi:10.1016/j.bja.2017.11.106 · Cited by 86
Study Duration for Clinical Trials with Survival Response and Early Stopping Rule
Kim, K., & Tsiatis, A. A. (1990) · Biometrics · doi:10.2307/2531632 · Cited by 86
Randomized Trial of Tamoxifen Versus Combined Tamoxifen and Octreotide LAR Therapy in the Adjuvant Treatment of Early-Stage Breast Cancer in Postmenopausal Women: NCIC CTG MA.14
Pritchard, K. I., Shepherd, L. E., Chapman, J. W., Norris, B. D., Cantin, J., Goss, P. E., Dent, S. F., Walde, D., Vandenberg, T. A., Findlay, B., et al. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.33.7006 · Cited by 85
Confidence Intervals Following Group Sequential Tests in Clinical Trials
Kim, K., & DeMets, D. L. (1987) · Biometrics · doi:10.2307/2531539 · Cited by 85
Self-citation
An Adaptive Group Sequential Design for Phase II/III Clinical Trials that Select a Single Treatment From Several
Kelly, P. J., Stallard, N., & Todd, S. (2005) · Journal of Biopharmaceutical Statistics · doi:10.1081/bip-200062857 · Cited by 84
The futility index. An approach to the cost-effective termination of randomized clinical trials
Ware, J. H., Muller, J. E., & D, E. B. M. (1985) · The American Journal of Medicine · doi:10.1016/0002-9343(85)90407-3 · Cited by 84
METRONIDAZOLE TO PREVENT PRETERM DELIVERY IN PREGNANT WOMEN WITH ASYMPTOMATIC BACTERIAL VAGINOSIS
Hristopher, J. C., Lebanoff, M. A. K., Auth, J., Illier, S. H. L. H., Hom, E., Hillip, R. P., Ugent, R. O. P. N., Ischer, M. O. L. F., Enneth, K., Eveno, J. L., et al. (2007) · Cited by 84
Management of Low-Risk Pulmonary Embolism Patients Without Hospitalization
Bledsoe, J. R., Woller, S. C., Stevens, S. M., Aston, V. T., Patten, R., Allen, T., Horne, B. D., Dong, L., Lloyd, J. F., Snow, G. L., et al. (2018) · CHEST Journal · doi:10.1016/j.chest.2018.01.035 · Cited by 85
Seamless phase II/III designs
Stallard, N., & Todd, S. (2010) · Statistical Methods in Medical Research · doi:10.1177/0962280210379035 · Cited by 83
Holmium Laser Enucleation versus Transurethral Resection in Patients with Benign Prostate Hyperplasia: An Updated Systematic Review with Meta-Analysis and Trial Sequential Analysis
Li, S., Zeng, X., Ruan, X., Weng, H., Liu, T.-Z., Wang, X., Zhang, C., Meng, Z., & Wang, X.-H. (2014) · PLoS ONE · doi:10.1371/journal.pone.0101615 · Cited by 83
Adjuvant Therapy With the Monoclonal Antibody Edrecolomab Plus Fluorouracil-Based Therapy Does Not Improve Overall Survival of Patients With Stage III Colon Cancer
Fields, A. L. A., Keller, A. M., Schwartzberg, L. S., Bernard, S. A., Kardinal, C. G., Cohen, A., Schulz, J., Eisenberg, P. D., Forster, J. K., & Wissel, P. S. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.18.5710 · Cited by 83
Group sequential enrichment design incorporating subgroup selection
Magnusson, B., & Turnbull, B. W. (2013) · Statistics in Medicine · doi:10.1002/sim.5738 · Cited by 86
The effect of subantimicrobial-dose–doxycycline periodontal therapy on serum biomarkers of systemic inflammation
Payne, J. B., Golub, L. M., Stoner, J. A., Lee, H., Reinhardt, R. A., Sorsa, T. A., & Slepian, M. J. (2011) · The Journal of the American Dental Association · doi:10.14219/jada.archive.2011.0165 · Cited by 83
Challenges and recommendations for blinding in behavioral interventions illustrated using a case study of a behavioral intervention to lower blood pressure
Friedberg, J. P., Lipsitz, S. R., & Natarajan, S. (2010) · Patient Education and Counseling · doi:10.1016/j.pec.2009.04.009 · Cited by 82
Current controversies in data monitoring for clinical trials
Pocock, S. (2006) · Clinical Trials · doi:10.1177/1740774506073467 · Cited by 82
Drotrecogin alfa (activated) (recombinant human activated protein C) for the treatment of severe sepsis
Bernard, G. R. (2003) · Critical Care Medicine · doi:10.1097/00003246-200301001-00012 · Cited by 82
Effect of Tamsulosin on Passage of Symptomatic Ureteral Stones
Meltzer, A. C., Burrows, P. K., Wolfson, A. B., Hollander, J. E., Kurz, M. C., Kırkalı, Z., Kusek, J. W., Mufarrij, P., Jackman, S. V., & Brown, J. (2018) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2018.2259 · Cited by 81
Simultaneous Durvalumab and Platinum-Based Chemoradiotherapy in Unresectable Stage III Non–Small Cell Lung Cancer: The Phase III PACIFIC-2 Study
Bradley, J. D., Sugawara, S., Lee, K. H., Ostoros, G., Demirkazik, A., Zemanová, M., Sriuranpong, V., Gelatti, A. C. Z., Menezes, J. J. D., Żurawski, B. A., et al. (2025) · Journal of Clinical Oncology · doi:10.1200/jco-25-00036 · Cited by 87
Adjusted significance levels for subgroup analyses in clinical trials
Spiessens, B., & Debois, M. (2010) · Contemporary Clinical Trials · doi:10.1016/j.cct.2010.08.011 · Cited by 81
Design of the stress incontinence surgical treatment efficacy trial (SISTEr)
Tennstedt, S. L. (2005) · Urology · doi:10.1016/j.urology.2005.06.089 · Cited by 81
Randomized phase IIB evaluation of weekly paclitaxel versus weekly paclitaxel with oncolytic reovirus (Reolysin®) in recurrent ovarian, tubal, or peritoneal cancer: An NRG Oncology/Gynecologic Oncology Group study
Cohn, D. E., Sill, M. W., Walker, J. L., O’Malley, D. M., Nagel, C. I., Rutledge, T. L., Bradley, W. H., Richardson, D. L., Moxley, K. M., & Aghajanian, C. A. (2017) · Gynecologic Oncology · doi:10.1016/j.ygyno.2017.07.135 · Cited by 81
The Evaluation of Subcutaneous Proleukin® (interleukin-2) in a Randomized International Trial
Emery, S., Abrams, D. I., Cooper, D. A., Darbyshire, J. H., Lane, H. C., Lundgren, J. D., & Neaton, J. D. (2002) · Controlled Clinical Trials · doi:10.1016/s0197-2456(01)00179-9 · Cited by 81
Surgical Removal vs Observation for Subfoveal Choroidal Neovascularization,Either Associated With the Ocular Histoplasmosis Syndrome or Idiopathic
Submacular Surgery Trials Research Group (2004) · Archives of Ophthalmology · doi:10.1001/archopht.122.11.1597 · Cited by 81
Closed Testing Procedures for Group Sequential Clinical Trials with Multiple Endpoints
Tang, D., & Geller, N. L. (1999) · Biometrics · doi:10.1111/j.0006-341x.1999.01188.x · Cited by 81
Policies for study monitoring and interim reporting of results.
Green, S., Fleming, T. R., & O'Fallon, J. R. (1987) · Journal of Clinical Oncology · doi:10.1200/jco.1987.5.9.1477 · Cited by 81
Design of Group Sequential Clinical Trials with Multiple Endpoints
Tang, D., Gnecco, C., & Geller, N. L. (1989) · Journal of the American Statistical Association · doi:10.1080/01621459.1989.10478836 · Cited by 81
The impact that group sequential tests would have made on ECOG clinical trials
Rosner, G. L., & Tsiatis, A. A. (1989) · Statistics in Medicine · doi:10.1002/sim.4780080413 · Cited by 81
The effect of intracoronary infusion of bone marrow-derived mononuclear cells on all-cause mortality in acute myocardial infarction: the BAMI trial
Mathur, A., Fernández‐Avilés, F., Bartunek, J., Belmans, A., Crea, F., Dowlut, S., Galiñanes, M., Good, M.-C., Hartikainen, J. E. K., Hauskeller, C., et al. (2020) · European Heart Journal · doi:10.1093/eurheartj/ehaa651 · Cited by 80
Milestone Survival: A Potential Intermediate Endpoint for Immune Checkpoint Inhibitors
Chen, T. (2015) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djv156 · Cited by 82
Sequential Comparison of Changes With Repeated Measurements Data
Lee, J. W., & DeMets, D. L. (1991) · Journal of the American Statistical Association · doi:10.1080/01621459.1991.10475106 · Cited by 79
Self-citation
Improving the Health of Patients With Cystic Fibrosis Through Newborn Screening
Farrell, P. M. (2000) · Advances in Pediatrics · doi:10.1016/s0065-3101(23)00095-6 · Cited by 80
Stopping clinical trials early for futility: retrospective analysis of several randomised clinical studies
Jitlal, M., Khan, I., Lee, S. M., & Hackshaw, A. K. (2012) · British Journal of Cancer · doi:10.1038/bjc.2012.344 · Cited by 79
Phase III Study Comparing Amrubicin Plus Cisplatin With Irinotecan Plus Cisplatin in the Treatment of Extensive-Disease Small-Cell Lung Cancer: JCOG 0509
Satouchi, M., Kotani, Y., Shibata, T., Ando, M., Nakagawa, K., Yamamoto, N., Ichinose, Y., Ohe, Y., Nishio, M., Hida, T., et al. (2014) · Journal of Clinical Oncology · doi:10.1200/jco.2013.53.5153 · Cited by 79
Practical Bayesian Design and Analysis for Drug and Device Clinical Trials
Hobbs, B. P., & Carlin, B. P. (2007) · Journal of Biopharmaceutical Statistics · doi:10.1080/10543400701668266 · Cited by 79
Phase III Trial of High-Dose Sequential Chemotherapy With Peripheral Blood Stem Cell Support Compared With Standard Dose Chemotherapy for First-Line Treatment of Advanced Ovarian Cancer: Intergroup Trial of the AGO-Ovar/AIO and EBMT
Möbus, V. J., Wandt, H., Frickhofen, N., Bengala, C., Champion, K. M., Kimmig, R., Ostermann, H., Hinke, A., & Ledermann, J. A. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.09.7527 · Cited by 78
Implementation of Group Sequential Logrank Tests in a Maximum Duration Trial
Lan, K. K. G., & Lachin, J. M. (1990) · Biometrics · doi:10.2307/2532094 · Cited by 78
Prevention of preterm delivery with vaginal progesterone in women with preterm labour (4P): randomised double‐blind placebo‐controlled trial
de Tejada, B. M., Karolinski, A., Ocampo, M., Laterra, C., Hösli, I., Fernández, D., Surbek, D., Huespe, M., Drack, G., Bunader, A., et al. (2014) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1111/1471-0528.13061 · Cited by 77
Adaptive Seamless Designs: Selection and Prospective Testing of Hypotheses
Jennison, C., & Turnbull, B. W. (2007) · Journal of Biopharmaceutical Statistics · doi:10.1080/10543400701645215 · Cited by 77
A randomized Phase III trial of thoracoscopic versus open esophagectomy for thoracic esophageal cancer: Japan Clinical Oncology Group Study JCOG1409
Kataoka, K., Takeuchi, H., Mizusawa, J., Ando, M., Tsubosa, Y., Koyanagi, K., Daiko, H., Matsuda, S., Nakamura, K., Kato, K., et al. (2016) · Japanese Journal of Clinical Oncology · doi:10.1093/jjco/hyv178 · Cited by 77
Selenium supplementation for critically ill adults
Allingstrup, M., & Afshari, A. (2015) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003703.pub3 · Cited by 78
Recent innovations in adaptive trial designs: A review of design opportunities in translational research
Kaizer, A. M., Belli, H. M., Ma, Z., Nicklawsky, A., Roberts, S. C., Wild, J. L., Wogu, A. F., Xiao, M., & Sabo, R. T. (2023) · Journal of Clinical and Translational Science · doi:10.1017/cts.2023.537 · Cited by 81
Phase III study of tri-modality combination therapy with induction docetaxel plus cisplatin and 5-fluorouracil versus definitive chemoradiotherapy for locally advanced unresectable squamous-cell carcinoma of the thoracic esophagus (JCOG1510: TRIANgLE)
Terada, M., Hara, H., Daiko, H., Mizusawa, J., Kadota, T., Hori, K., Ogawa, H., Ogata, T., Sakanaka, K., Sakamoto, T., et al. (2019) · Japanese Journal of Clinical Oncology · doi:10.1093/jjco/hyz112 · Cited by 76

Authors: GORDON LAN, K. K., & DEMETS, D. L.
Affiliations: University of Wisconsin–Madison (US)
Venue: Biometrika
Publisher: Oxford University Press (OUP)
Published: 1983
Volume: 70
Issue: 3
Pages: 659-663
ISSN: 0006-3444 (ISSN-L)
1464-3510
DOI: 10.1093/biomet/70.3.659
OpenAlex: W1990639292
Cited by: 2,310
References: 10
Citations by year: 2026: 51 · 2025: 69 · 2024: 80 · 2023: 78 · 2022: 63 · 2021: 73 · 2020: 77 · 2019: 96 · 2018: 76 · 2017: 89 · 2016: 90 · 2015: 72 · 2014: 112 · 2013: 73 · 2012: 101
FWCI: 7.06
Type: journal article
Language: en
Open access: closed
Locations: Biometrika (publishedVersion)
Topics: Physical Sciences › Mathematics › Statistics and Probability › Statistical Methods in Clinical Trials
Physical Sciences › Mathematics › Statistics and Probability › Probability and Statistical Research
Physical Sciences › Mathematics › Statistics and Probability › Statistical Methods and Bayesian Inference
Keywords: clinical trials, early stopping, alpha spending functions, sequential analysis, decision time, error rate control

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Discrete sequential boundaries for clinical trials

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks